chr16-1229627-A-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_024164.6(TPSB2):c.172T>A(p.Phe58Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000136 in 146,678 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 10/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024164.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TPSB2 | NM_024164.6 | c.172T>A | p.Phe58Ile | missense_variant | 3/6 | ENST00000606293.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TPSB2 | ENST00000606293.5 | c.172T>A | p.Phe58Ile | missense_variant | 3/6 | 1 | NM_024164.6 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000136 AC: 2AN: 146678Hom.: 0 Cov.: 28
GnomAD3 exomes AF: 0.0000122 AC: 3AN: 245128Hom.: 0 AF XY: 0.0000226 AC XY: 3AN XY: 132928
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000137 AC: 20AN: 1456566Hom.: 0 Cov.: 89 AF XY: 0.0000166 AC XY: 12AN XY: 724608
GnomAD4 genome AF: 0.0000136 AC: 2AN: 146678Hom.: 0 Cov.: 28 AF XY: 0.0000140 AC XY: 1AN XY: 71518
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 16, 2023 | The c.172T>A (p.F58I) alteration is located in exon 3 (coding exon 2) of the TPSB2 gene. This alteration results from a T to A substitution at nucleotide position 172, causing the phenylalanine (F) at amino acid position 58 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at